Clinical Trials

Inclusion Criteria: 

• Male or female aged ≥ 18 years.
• The subject or the subject's LAR voluntarily agrees that the subject will participate in this study and is able to understand and sign the Informed Consent Form (ICF).
• Have a medical condition that requires a PIVC anticipated to last for at least 48 hours.
• Have intact skin at the site of insertion.
• If the patient has an existing IV in one arm he/she must have a viable contralateral arm for additional PIVC insertion.

Exclusion Criteria:

• Are currently participating in another medical device or pharmaceutical study.
• In the opinion of the Investigator, would not be suitable candidates for this study.
• The subject or his/her LAR is an employee of the Investigator or study center or the sponsor.
• Are an employee of the Investigator or study center, have direct involvement in the study or other studies under the direction of that Investigator or study center, or are a family member of the employees or the Investigator.
• Patient has an existing non-study related IV.
• Have a laboratory confirmed bloodstream infection within 48 hours prior to participation in the study. The assessment is based on clinical observations and not routine for all subjects.
• Patient has an existing IV in one arm and has a medical condition prohibiting contralateral PIVC insertion.
• Was removed from any Stage of the study due to an AE associated with the PIVC.